文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

体重指数能否预测急性肺损伤/急性呼吸窘迫综合征患者的临床结局?一项Meta分析

Can body mass index predict clinical outcomes for patients with acute lung injury/acute respiratory distress syndrome? A meta-analysis.
PubMed 文献 · Crit Care · 2017-02-22
一句话结论Meta分析显示,在ARDS患者中,肥胖与病态肥胖与较低死亡率相关,而低体重与较高死亡率相关。

该Meta分析检索Pubmed、Embase、Medline、Cochrane CENTRAL和ISI Web of Science(1946年至2016年7月),纳入5项试验共6268例急性肺损伤/急性呼吸窘迫综合征患者,采用随机效应模型计算OR或MD。与正常体重相比,低体重与较高死亡率相关(OR 1.59,95%CI 1.22,2.08,P=0.0006),肥胖和病态肥胖与较低死亡率相关(OR 0.68,95%CI 0.57,0.80,P<0.00001;OR 0.72,95%CI 0.56,0.93,P=0.01);病态肥胖患者无机械通气天数更长(MD 2.64,95%CI 0.60,4.67,P=0.01),但ICU和住院时间不受BMI影响。作者结论为肥胖和病态肥胖与ARDS患者较低死亡率相关。

要点

  • 与正常体重相比,低体重ARDS患者死亡率更高(OR 1.59,95%CI 1.22,2.08,P=0.0006)。
  • 与正常体重相比,肥胖ARDS患者死亡率更低(OR 0.68,95%CI 0.57,0.80,P<0.00001)。
  • 与正常体重相比,病态肥胖ARDS患者死亡率更低(OR 0.72,95%CI 0.56,0.93,P=0.01)。
  • 病态肥胖患者无机械通气天数更长(MD 2.64,95%CI 0.60,4.67,P=0.01),但ICU和住院时间不受BMI影响。
  • 正常体重与超重患者间ICU住院时间(I²=71%,χ²=10.27,P=0.02)和无机械通气天数(I²=89%,χ²=18.45,P<0.0001)存在统计学异质性。

适用人群与场景

  • 急性肺损伤/急性呼吸窘迫综合征患者,共6268例,来自5项试验。

研究设计与关键结果

  • 研究类型为Meta分析,纳入5项试验共6268例急性肺损伤/急性呼吸窘迫综合征患者,检索Pubmed、Embase、Medline、Cochrane CENTRAL和ISI Web of Science(1946年至2016年7月),采用随机效应模型计算OR或MD。
  • 主要终点为未校正死亡率:与正常体重相比,低体重与较高死亡率相关(OR 1.59,95%CI 1.22,2.08,P=0.0006),肥胖与较低死亡率相关(OR 0.68,95%CI 0.57,0.80,P<0.00001),病态肥胖与较低死亡率相关(OR 0.72,95%CI 0.56,0.93,P=0.01)。
  • 次要终点:病态肥胖患者无机械通气天数更长(MD 2.64,95%CI 0.60,4.67,P=0.01);ICU和住院时间不受BMI影响。
  • 正常体重与超重患者间ICU住院时间存在统计学异质性(I²=71%,χ²=10.27,P=0.02),无机械通气天数存在统计学异质性(I²=89%,χ²=18.45,P<0.0001)。

证据类型、等级与局限

  • 证据类型:Meta分析(5项试验,共6268例患者)。
  • 局限:分析缺乏对年龄、性别、疾病严重程度、合并症及结局参数交互作用的校正。

对床旁实践的改变

  • 作者结论认为,肥胖和病态肥胖与ARDS患者较低死亡率相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The effects of body mass index (BMI) on the prognosis of acute respiratory distress syndrome (ARDS) are controversial. We aimed to further determine the relationship between BMI and the acute outcomes of patients with ARDS.

METHODS: We searched the Pubmed, Embase, Medline, Cochrane Central Register of Controlled Trials (CENTRAL), and ISI Web of Science for trials published between 1946 and July 2016, using "BMI" or "body mass index" or "overweight" or "obese" and "ARDS" or "ALI" or "acute respiratory distress syndrome" or "acute lung injury", without limitations on publication type or language. Heterogeneity and sensitivity analyses were conducted, and a random-effects model was applied to calculate the odds ratio (OR) or mean difference (MD). Review Manager (RevMan) was used to test the hypothesis using the Mann-Whitney U test. The primary outcome was unadjusted mortality, and secondary outcomes included mechanical ventilation (MV)-free days and length of stay (LOS) in the intensive care unit (ICU) and in hospital.

RESULTS: Five trials with a total of 6268 patients were pooled in our final analysis. There was statistical heterogeneity between normal-weight and overweight patients in LOS in the ICU (I 2 = 71%, χ 2 = 10.27, P = 0.02) and in MV-free days (I 2 = 89%, χ 2 = 18.45, P < 0.0001). Compared with normal weight, being underweight was associated with higher mortality (OR 1.59, 95% confidence interval (CI) 1.22, 2.08, P = 0.0006), while obesity and morbid obesity were more likely to result in lower mortality (OR 0.68, 95% CI 0.57, 0.80, P < 0.00001; OR 0.72, 95% CI 0.56, 0.93, P = 0.01). MV-free days were much longer in patients with morbid obesity (MD 2.64, 95% CI 0.60, 4.67, P = 0.01), but ICU and hospital LOS were not influenced by BMI. An important limitation of our analysis is the lack of adjustment for age, sex, illness severity, comorbid illness, and interaction of outcome parameters.

CONCLUSIONS: Obesity and morbid obesity are associated with lower mortality in patients with ARDS.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Ni YN, Luo J, Yu H, et al. Can body mass index predict clinical outcomes for patients with acute lung injury/acute respiratory distress syndrome? A meta-analysis. Crit Care. 2017. PMID: 28222804. doi:10.1186/s13054-017-1615-3

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。